Head for the Cure Austin

Join some of the Plus Therapeutics team at the @HeadfortheCure 5K in Austin, TX on March 24! They will be out supporting the local community, cancer research, and “Defeating Brain Cancer Step by Step.” We hope to see you there 🏃🏃‍♂️🏃‍♀️ Event information:...

Corporate Presentation

AVAILABLE NOW: The new Plus Therapeutics corporate presentation, which reflects our current data, milestones, and pipeline, is on our website. View it directly here: https://bit.ly/3PiHClj Questions about anything or interested in learning more? Visit our website at...

LM Cohort 5 Completion

BREAKING NEWS! We have completed dosing in Cohort 5 of our ongoing ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases, with a total of 18 patients have been dosed in the trial to date. The trial is STILL ENROLLING and accepting new...

“Glioblastoma AKA GBM” Sponsorship

We are thrilled to announce our sponsorship with @glioblastomaresearch this upcoming season on their “Glioblastoma AKA GBM” podcast! 🧠 We appreciate their goal of raising awareness and funds for new global, cutting-edge research to find a cure for...

Miami Breast Conference

Some of our clinical team will be attending the #MiamiBreast Cancer Conference this week, as it relates to our Leptomeningeal Metastases clinical trial for Metastatic Breast Cancer patients. If you are interested in connecting with the team there, send us a DM. See...